Dually eligible individuals, those eligible for Medicaid and Medicare services, often experience fragmented care and poor health outcomes. Integrated products that coordinate care across both programs may help to address these challenges. In May 2022, the Centers for Medicare & Medicaid Services (CMS) began to sunset one integrated care plan type, Medicare-Medicaid Plans (MMPs) under the Financial Alignment Initiative demonstration, and encouraged demonstration states to transition enrollees to another growing integrated product, Medicare Advantage dual eligible special needs plans (D-SNPs). Levels of integration vary across D-SNP types and recent federal rulemaking has continued to define requirements for and further integration in these plans.
To provide Commissioners with the opportunity to engage with the broader conversation about integration for the dually eligible population, we invited experts to participate in a moderated discussion on the MMP transition, considerations for states developing integrated D-SNPs, and the future of integrated care for this population.
Panelists included:
- Tim Engelhardt, Director, Medicare-Medicaid Coordination Office, CMS
- Michael Monson, Chief Executive Officer and President, Altarum
- Michelle Herman Soper, Vice President of Public Policy, Commonwealth Care Alliance
*This panel did not include slides.